Inhibitory effect of 22-oxa-1,25-dihydroxyvitamin D₃, maxacalcitol, on the proliferation of pancreatic cancer cell linesKAWA, Shigeyuki; YOSHIZAWA, Kaname; NIKAIDO, Toshio et al.Journal of steroid biochemistry and molecular biology. 2005, Vol 97, Num 1-2, pp 173-177, issn 0960-0760, 5 p.Conference Paper

Fonction et potentialités thérapeutiques du récepteur D₃ de la dopamine : Du gène au comportement : nouveau cheminement en direction de nouveaux agents psychotropes = Function and therapeutic potentials of the dopamine D₃ receptor : From gene to behaviourSOKOLOFF, P; DIAZ, J; BORDET, R et al.Comptes rendus des séances de la Société de biologie et de ses filiales. 1998, Vol 192, Num 6, pp 1111-1125, issn 0037-9026Article

Dopamine D₃ receptor antagonists as therapeutic agentsJOYCE, Jeffrey N; MILLAN, Mark J.Drug discovery today. 2005, Vol 10, Num 13, pp 917-925, issn 1359-6446, 9 p.Article

Identification of a 2-phenyl-substituted octahydrobenzo[f]quinoline as a dopamine D₃ receptor-selective full agonist ligandCLARK, Alia H; MCCORVY, John D; CONLEY, Jason M et al.Bioorganic & medicinal chemistry. 2012, Vol 20, Num 21, pp 6366-6374, issn 0968-0896, 9 p.Article

Functional rescue of the inactive splice variant of the dopamine D₃ receptor D_3nfSCARSELLI, Marco; NOVI, Francesca; CORSINI, Giovanni U et al.Brain research. 2003, Vol 987, Num 2, pp 244-247, issn 0006-8993, 4 p.Article

Using prepulse inhibition to detect functional D3 receptor antagonism: Effects of WC10 and WC44WEBER, Martin; CHANG, Wei-Li; DURBIN, John P et al.Pharmacology, biochemistry and behavior. 2009, Vol 93, Num 2, pp 141-147, issn 0091-3057, 7 p.Article

Genetic association between the dopamine D3 gene polymorphism (Ser9Gly) and schizophrenia in Japanese populations : Evidence from a case-control study and meta-analysisUTSUNOMIYA, Kensuke; SHINKAI, Takahiro; DE LUCA, Vincenzo et al.Neuroscience letters. 2008, Vol 444, Num 2, pp 161-165, issn 0304-3940, 5 p.Article

D₃ Dopamine Receptor Regulation of ETB Receptors in Renal Proximal Tubule Cells From WKY and SHRsCHANGQING YU; ZHIWEI YANG; ASICO, Laureano D et al.American journal of hypertension. 2009, Vol 22, Num 8, pp 877-883, issn 0895-7061, 7 p.Article

Further evidence of no association between Ser9Gly polymorphism of dopamine D3 receptor gene and schizophreniaCHEN, C.-H; LIU, M.-Y; WEI, F.-C et al.American journal of medical genetics. 1997, Vol 74, Num 1, pp 40-43, issn 0148-7299Article

The preferential dopamine D₃ receptor ligand, (+)-UH232, is a partial agonistGRIFFON, N; PILON, C; SCHWARTZ, J.-C et al.European journal of pharmacology. 1995, Vol 282, Num 1-3, pp R3-R4, issn 0014-2999Article

Localization and function of the D₃ dopamine receptorSOKOLOFF, P; GIROS, B; MARTRES, M. P et al.Arzneimittel-Forschung. 1992, Vol 42, Num 2A, pp 224-230, issn 0004-4172Conference Paper

Le troisiéme récepteur de la dopamine : une nouvelle cible d'action des neuroleptiques = The D3 dopamine receptor as a new target for neurolepticsGIROS, B.La Semaine des hôpitaux de Paris. 1991, Vol 67, Num 32, pp 1452-1454, issn 0037-1777Article

Structure of the Human Dopamine D3 Receptor in Complex with a D2/D3 Selective AntagonistCHIEN, EllenY T; WEI LIU; STEVENS, Raymond C et al.Science (Washington, D.C.). 2010, Vol 330, Num 6007, pp 1091-1095, issn 0036-8075, 5 p.Article

The splice variant D3nf reduces ligand binding to the D3 dopamine receptor: evidence for heterooligomerizationELMHURST, J. L; ZHIDONG XIE; O'DOWD, B. F et al.Molecular brain research. 2000, Vol 80, Num 1, pp 63-74, issn 0169-328XArticle

Blonanserin, an Antipsychotic and Dopamine D₂/D₃ Receptor Antagonist, and Ameliorated Alcohol DependenceTAKAKI, Manabu; UJIKE, Hiroshi.Clinical neuropharmacology. 2013, Vol 36, Num 2, pp 68-69, issn 0362-5664, 2 p.Article

Cariprazine (RGH-188), a potent D_3/D₂ dopamine receptor partial agonist, binds to dopamine D₃ receptors in vivo and shows antipsychotic-like and procognitive effects in rodentsGYERTYAN, Istvan; KISS, Béla; AGAI CSONGOR, Eva et al.Neurochemistry international. 2011, Vol 59, Num 6, pp 925-935, issn 0197-0186, 11 p.Article

IL-22 : A critical mediator in mucosal host defenseAUJLA, S. J; KOLLS, J. K.Journal of molecular medicine (Berlin. Print). 2009, Vol 87, Num 5, pp 451-454, issn 0946-2716, 4 p.Article

Welche Kältemittel in der Zukunft? = Which refrigerant in the future?DOÊRING, R.Die Kälte und Klimatechnik. 1990, Vol 43, Num 9, pp 472-482, issn 0343-2246, 6 p.Article

Intensification of the development of ethanol dependence in mice lacking dopamine D₃ receptorNARITA, Minoru; SOMA, Miho; TAMAKI, Hiroko et al.Neuroscience letters. 2002, Vol 324, Num 2, pp 129-132, issn 0304-3940Article

Effects of the D₃ and autoreceptor-preferring dopamine antagonist (+)-UH232 in schizophreniaLAHTI, A. C; WEILER, M; CARLSSON, A et al.Journal of neural transmission. 1998, Vol 105, Num 6-7, pp 719-734, issn 0300-9564Article

Functional implications of multiple dopamine receptor subtypes : the D₁/D₃ receptor coexistenceSCHWARTZ, J.-C; DIAZ, J; BORDET, R et al.Brain research reviews. 1998, Vol 26, Num 2-3, pp 236-242, issn 0165-0173Conference Paper

No evidence of association between structural polymorphism at the dopamine D3 receptor locus and alcoholism in the JapaneseHIGUCHI, S; MURAMATSU, T; MATSUSHITA, S et al.American journal of medical genetics. 1996, Vol 67, Num 4, pp 412-414, issn 0148-7299Article

Structural organization of the murine D₃ dopamine receptor geneBAE-HANG PARK; FISHBURN, C. S; CARMON, S et al.Journal of neurochemistry. 1995, Vol 64, Num 2, pp 482-486, issn 0022-3042Article

Possible association between the dopamine D₃ receptor gene and bipolar affective disorderABBAS PARSIAN; SUMITRA CHAKRAVERTY; TODD, R. D et al.American journal of medical genetics. 1995, Vol 60, Num 3, pp 234-237, issn 0148-7299Article

Functional expression and characterization of human D₂ and D₃ dopamine receptorsPOTENZA, M. N; GRAMINSKI, G. F; SCHMAUSS, C et al.The Journal of neuroscience. 1994, Vol 14, Num 3, pp 1463-1476, issn 0270-6474, 2Article